Erythromycin, 2'-(ethyl butanedioate)
CAS: 1264-62-6
Rif. AN-AG000SQT
1g | Fuori produzione | ||
5g | Fuori produzione | ||
25g | Fuori produzione | ||
100mg | Fuori produzione | ||
250mg | Fuori produzione |
Informazioni sul prodotto
Nome:
Erythromycin, 2'-(ethyl butanedioate)
Sinonimi:
- [u'E-Mycin E', u'EMycin E', u'EryPed', u'Erythromycin Ethylsuccinate', u'Erythroped', u'Ethyl Succinate, Eyrthromycin', u'Ethylsuccinate, Erythromycin', u'Eyrthromycin Ethyl Succinate', u'Monomycin', u'Pediamycin', u'Succinate, Eyrthromycin Ethyl', u'Wyamycin E', u'erythromycin ethylsuccinate', u'Erythroped', u'Pediamycin', u'Wyamycin E', u'EryPed', u'1264-62-6', u'Erythrocin ethyl succinate', u'E-Mycin E', u'Erythromycin ethyl succinate', u"Erythromycin 2'-(ethyl succinate)", u'ERY-PED', u'PEDIAMYCIN 400', u'E.E.S', u'Erythromycin, ethyl succinate', u'UNII-1014KSJ86F', u'MLS001074901', u'HSDB 3075', u'C43H75NO16', u'Erythromycin, mono(ethyl succinate)', u'EINECS 215-033-8', u'BRN 0077638', u'Erythromycin, mono(ethyl succinate) (ester)', u'CHEBI:31555', u'1014KSJ86F', u'Succinic acid, monoethyl ester, monoester with erythromycin', u'SMR000058868', u'succinicacid,monoethylester,monoesterwitherythromycin', u'EES Granules', u'EES (Antiobiotic)', u'Eyrthromycin Ethyl Succinate', u'Wyamycin', u'E.E.S.', u'Erythromycin ethylsuccinate [JAN]', u'NCGC00183038-01', u'41342-53-4', u'E-Mycin-E', u'E.E.S 200', u'E.E.S 400', u'Eryped (TN)', u'Erythrocin W (TN)', u'Erythromycin ethylsuccinate [USP:JAN]', u'erythrocinethylsuccinate', u'Spectrum_001046', u'AC1L9FGS', u'Spectrum2_000983', u'Spectrum3_000419', u'Spectrum4_000536', u'Spectrum5_000668', u'erythromycin-ethylsuccinate', u'DSSTox_CID_2993', u'Erythromycin-ethyl succinate', u'DSSTox_RID_76821', u'DSSTox_GSID_22993', u'Erythromycin A Ethylsuccinate', u'SCHEMBL18259', u'BSPBio_001978', u'KBioGR_001171', u'KBioSS_001526', u'4-18-00-07416 (Beilstein Handbook Reference)', u'MLS000028651', u'MLS001076672', u'DivK1c_000764', u'SPECTRUM1500279', u'SPBio_001045', u'cid_443953', u'CHEMBL1200688', u'DTXSID4022993', u'erythromycin,mono(ethylsuccinate)', u'BDBM96262', u'E.E.S. (TN)', u'HMS502G06', u'KBio1_000764', u'KBio2_001526', u'KBio2_004094', u'KBio2_006662', u'KBio3_001198', u'NINDS_000764', u'NSYZCCDSJNWWJL-YXOIYICCSA-N', u'HMS1923I21', u'HMS2091D03', u'Pharmakon1600-01500279', u'ERITHROMYCIN ETHYL SUCCINATE', u'HY-B0957', u"2'-(Ethyl butanedioate)erythromycin", u'Tox21_113497', u'CCG-40201', u'LMPK05000001', u'MFCD00084692', u'NSC756758', u's4060', u'AKOS008145410', u'ZINC169356230', u'CS-4434', u'E.E.S. 200', u'E.E.S. 400', u'MCULE-3725545409', u'NSC-756758', u'Erythromycin ethylsuccinate (JP17/USP)', u'erythromycin,mono(ethylsuccinate)(ester)', u'IDI1_000764', u'NCGC00021382-03', u'CPD000058868', u'SAM002548941', u'CAS-1264-62-6', u'Erythromycin mono(ethyl succinate) (ester)', u'SBI-0051367.P003', u'LS-147492', u'C12796', u'D01361', u'AB00051980_11', u'AB00051980_12', u'SR-05000001617', u'SR-05000001617-1', u'Succinic acid monoethyl ester monoester with erythromycin', u'oxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] 1-O-ethyl butanedioate', u'(2S,3R,4S,6R)-4-(dimethylamino)-2-(((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl)oxy)-6-methyltetrahydro-2H-pyran-3-yl ethyl succinate']
- (2R,3S,4R,6S)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name)
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione
- 4-(dimethylamino)-2-({14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl}oxy)-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name)
- 4-Ethoxy-4-Oxo-Butanoate
- Anamycin
- Arpimycin
- Durapaediat
- E-Mycin e
- Eritrocina
- Vedi altri sinonimi
- EryPed
- Eryliquid
- Erythro ES
- Erythro-Holz
- Erythrocin ethyl succinate
- Erythromycin Ethly Succinate.
- Erythromycin Ethyl Succinate
- Erythromycin Ethylsuccinate
- Erythromycin, 2′-(ethyl butanedioate)
- Erythromycin, 2′-(ethyl succinate)
- Erythromycin, mono(ethyl succinate) (ester)
- Erythroped
- Esinol
- Evesin
- Monomycin
- Oxacyclotetradecane, erythromycin deriv.
- Paediathrocin
- Pediamycin
- Refkas
- Sigapedil
- Succinic acid, ethyl ester, monoester with erythromycin
- Wyamycin E
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Indagoo
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
862.0527
Formula:
C43H75NO16
Colore/Forma:
Solid
InChI:
InChI=1S/C43H75NO16/c1-15-29-43(11,52)36(48)24(5)33(47)22(3)20-41(9,51)38(25(6)34(26(7)39(50)57-29)59-32-21-42(10,53-14)37(49)27(8)56-32)60-40-35(28(44(12)13)19-23(4)55-40)58-31(46)18-17-30(45)54-16-2/h22-29,32,34-38,40,48-49,51-52H,15-21H2,1-14H3/t22-,23-,24+,25+,26-,27+,28+,29-,32+,34+,35-,36-,37+,38-,40+,41-,42-,43-/m1/s1
InChI key:
NSYZCCDSJNWWJL-YXOIYICCSA-N
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA: